IMMUNOSUPPRESSING AGENT CONTAINING MONOCLONAL ANTILYMPHOKINE ANTIBODY AS ACTIVE COMPONENT

PURPOSE:To obtain an immunosuppressing agent applicable to the patient of immune diseases including cancer, viral disease, immunoinsufficiency, rejection in organ transplantation, etc., by using a monoclonal antilymphokine antibody as active component. CONSTITUTION:The objective agent contains, as a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SAKAGAMI KENICHI, ORITA SHIGEZO, HAMURO JUNJI, HANZAWA YOSHIAKI
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PURPOSE:To obtain an immunosuppressing agent applicable to the patient of immune diseases including cancer, viral disease, immunoinsufficiency, rejection in organ transplantation, etc., by using a monoclonal antilymphokine antibody as active component. CONSTITUTION:The objective agent contains, as an active component, a nonclonal antilymphokine antibody produced by the cell culture of lymphocyte, malignant cell, hybridoma, etc., or from bacterial cell or cell having a gene originated from the above cell. For example, remarkable effect can be achieved for the suppression of the rejection in cardiac transplantation by using a monoclonal anti-IL2 antibody produced from a cell or hybridoma prepared b y sensitizing human lymphocyte with IL2 and transforming with a virus (e.g. EB virus), etc.